Annual EBIT
-$391.49 M
-$2.44 M-0.63%
31 December 2023
Summary:
Agios Pharmaceuticals annual earnings before interest & taxes is currently -$391.49 million, with the most recent change of -$2.44 million (-0.63%) on 31 December 2023. During the last 3 years, it has fallen by -$13.07 million (-3.45%). AGIO annual EBIT is now -2253.96% below its all-time high of -$15.83 million.AGIO EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$102.81 M
+$3.01 M+2.84%
30 September 2024
Summary:
Agios Pharmaceuticals quarterly earnings before interest & taxes is currently -$102.81 million, with the most recent change of +$3.01 million (+2.84%) on 30 September 2024. Over the past year, it has increased by +$3.47 million (+3.26%). AGIO quarterly EBIT is now -3304.83% below its all-time high of $3.21 million, reached on 30 September 2014.AGIO Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$406.98 M
-$1.91 M-0.47%
30 September 2024
Summary:
Agios Pharmaceuticals TTM earnings before interest & taxes is currently -$406.98 million, with the most recent change of -$1.91 million (-0.47%) on 30 September 2024. Over the past year, it has dropped by -$15.49 million (-3.96%). AGIO TTM EBIT is now -7631.33% below its all-time high of -$5.26 million, reached on 31 March 2012.AGIO TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AGIO EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +3.3% | -4.0% |
| 3 y3 years | -3.5% | +1.9% | -7.5% |
| 5 y5 years | -23.8% | -1338.5% | -26.9% |
AGIO EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -3.5% | at low | -13.5% | +3.3% | -8.7% | at low |
| 5 y | 5 years | -23.8% | at low | -1338.5% | +3.3% | -57.9% | at low |
| alltime | all time | -2254.0% | at low | -3304.8% | +6.4% | -7631.3% | at low |
Agios Pharmaceuticals EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$102.81 M(-2.8%) | -$406.98 M(+0.5%) |
| June 2024 | - | -$105.82 M(+14.9%) | -$405.06 M(+3.1%) |
| Mar 2024 | - | -$92.07 M(-13.4%) | -$392.95 M(+0.4%) |
| Dec 2023 | -$391.49 M(+0.6%) | -$106.28 M(+5.3%) | -$391.49 M(+1.8%) |
| Sept 2023 | - | -$100.90 M(+7.7%) | -$384.38 M(+2.6%) |
| June 2023 | - | -$93.70 M(+3.4%) | -$374.57 M(-1.0%) |
| Mar 2023 | - | -$90.61 M(-8.6%) | -$378.51 M(-2.7%) |
| Dec 2022 | -$389.05 M(+2.8%) | -$99.17 M(+8.9%) | -$389.05 M(-1.4%) |
| Sept 2022 | - | -$91.09 M(-6.7%) | -$394.70 M(-0.0%) |
| June 2022 | - | -$97.64 M(-3.5%) | -$394.76 M(+1.7%) |
| Mar 2022 | - | -$101.14 M(-3.5%) | -$388.35 M(+2.6%) |
| Dec 2021 | -$378.42 M(+12.7%) | -$104.83 M(+15.0%) | -$378.42 M(+5.4%) |
| Sept 2021 | - | -$91.15 M(-0.1%) | -$358.92 M(+3.1%) |
| June 2021 | - | -$91.22 M(+0.0%) | -$348.06 M(+2.3%) |
| Mar 2021 | - | -$91.22 M(+6.9%) | -$340.10 M(+1.2%) |
| Dec 2020 | -$335.92 M(+6.2%) | -$85.33 M(+6.3%) | -$335.92 M(+30.3%) |
| Sept 2020 | - | -$80.29 M(-3.6%) | -$257.73 M(-9.1%) |
| June 2020 | - | -$83.26 M(-4.3%) | -$283.61 M(-8.6%) |
| Mar 2020 | - | -$87.03 M(+1117.7%) | -$310.22 M(-3.3%) |
| Dec 2019 | -$316.27 M(-8.6%) | -$7.15 M(-93.3%) | -$320.67 M(-18.5%) |
| Sept 2019 | - | -$106.17 M(-3.4%) | -$393.43 M(+1.8%) |
| June 2019 | - | -$109.87 M(+12.7%) | -$386.42 M(+10.6%) |
| Mar 2019 | - | -$97.48 M(+22.0%) | -$349.50 M(+1.0%) |
| Dec 2018 | -$346.03 M | -$79.91 M(-19.4%) | -$346.03 M(-2.9%) |
| Sept 2018 | - | -$99.16 M(+35.9%) | -$356.25 M(+6.0%) |
| June 2018 | - | -$72.95 M(-22.4%) | -$336.11 M(-3.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2018 | - | -$94.01 M(+4.3%) | -$347.76 M(+8.4%) |
| Dec 2017 | -$320.79 M(+59.6%) | -$90.13 M(+14.1%) | -$320.79 M(+11.4%) |
| Sept 2017 | - | -$79.02 M(-6.6%) | -$288.07 M(+5.7%) |
| June 2017 | - | -$84.60 M(+26.2%) | -$272.57 M(+11.5%) |
| Mar 2017 | - | -$67.05 M(+16.8%) | -$244.44 M(+21.6%) |
| Dec 2016 | -$200.99 M(+69.3%) | -$57.41 M(-9.6%) | -$200.99 M(+9.0%) |
| Sept 2016 | - | -$63.51 M(+12.5%) | -$184.47 M(+14.3%) |
| June 2016 | - | -$56.47 M(+139.3%) | -$161.44 M(+17.8%) |
| Mar 2016 | - | -$23.59 M(-42.3%) | -$137.10 M(+15.5%) |
| Dec 2015 | -$118.70 M(+119.3%) | -$40.90 M(+1.0%) | -$118.70 M(+13.6%) |
| Sept 2015 | - | -$40.48 M(+26.0%) | -$104.53 M(+71.8%) |
| June 2015 | - | -$32.13 M(+518.5%) | -$60.85 M(+29.3%) |
| Mar 2015 | - | -$5.20 M(-80.6%) | -$47.04 M(-13.1%) |
| Dec 2014 | -$54.13 M(+39.2%) | -$26.73 M(-933.1%) | -$54.13 M(+36.5%) |
| Sept 2014 | - | $3.21 M(-117.5%) | -$39.65 M(-26.5%) |
| June 2014 | - | -$18.33 M(+49.2%) | -$53.92 M(+22.2%) |
| Mar 2014 | - | -$12.28 M(+0.3%) | -$44.12 M(+13.5%) |
| Dec 2013 | -$38.88 M(+69.1%) | -$12.24 M(+10.6%) | -$38.88 M(+17.3%) |
| Sept 2013 | - | -$11.07 M(+29.8%) | -$33.14 M(+21.9%) |
| June 2013 | - | -$8.53 M(+21.0%) | -$27.18 M(+9.7%) |
| Mar 2013 | - | -$7.05 M(+8.5%) | -$24.78 M(+7.7%) |
| Dec 2012 | -$23.00 M(+38.3%) | -$6.50 M(+27.1%) | -$22.99 M(+39.4%) |
| Sept 2012 | - | -$5.11 M(-16.5%) | -$16.50 M(+44.9%) |
| June 2012 | - | -$6.12 M(+16.3%) | -$11.39 M(+116.3%) |
| Mar 2012 | - | -$5.26 M | -$5.26 M |
| Dec 2011 | -$16.63 M | - | - |
FAQ
- What is Agios Pharmaceuticals annual earnings before interest & taxes?
- What is the all time high annual EBIT for Agios Pharmaceuticals?
- What is Agios Pharmaceuticals quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Agios Pharmaceuticals?
- What is Agios Pharmaceuticals quarterly EBIT year-on-year change?
- What is Agios Pharmaceuticals TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Agios Pharmaceuticals?
- What is Agios Pharmaceuticals TTM EBIT year-on-year change?
What is Agios Pharmaceuticals annual earnings before interest & taxes?
The current annual EBIT of AGIO is -$391.49 M
What is the all time high annual EBIT for Agios Pharmaceuticals?
Agios Pharmaceuticals all-time high annual earnings before interest & taxes is -$15.83 M
What is Agios Pharmaceuticals quarterly earnings before interest & taxes?
The current quarterly EBIT of AGIO is -$102.81 M
What is the all time high quarterly EBIT for Agios Pharmaceuticals?
Agios Pharmaceuticals all-time high quarterly earnings before interest & taxes is $3.21 M
What is Agios Pharmaceuticals quarterly EBIT year-on-year change?
Over the past year, AGIO quarterly earnings before interest & taxes has changed by +$3.47 M (+3.26%)
What is Agios Pharmaceuticals TTM earnings before interest & taxes?
The current TTM EBIT of AGIO is -$406.98 M
What is the all time high TTM EBIT for Agios Pharmaceuticals?
Agios Pharmaceuticals all-time high TTM earnings before interest & taxes is -$5.26 M
What is Agios Pharmaceuticals TTM EBIT year-on-year change?
Over the past year, AGIO TTM earnings before interest & taxes has changed by -$15.49 M (-3.96%)